Sugai K, Nakamura M, Okano H, Nagoshi N
Brain Spine. 2025; 5:104207.
PMID: 40027291
PMC: 11870206.
DOI: 10.1016/j.bas.2025.104207.
Kanemura Y, Yamamoto A, Katsuma A, Fukusumi H, Shofuda T, Kanematsu D
Cells. 2024; 13(8.
PMID: 38667286
PMC: 11048851.
DOI: 10.3390/cells13080671.
Nagoshi N, Sugai K, Okano H, Nakamura M
Spine Surg Relat Res. 2024; 8(1):22-28.
PMID: 38343414
PMC: 10853617.
DOI: 10.22603/ssrr.2023-0135.
Nguyen T, Chooi W, Jeon H, Chen J, Tan J, Roxby D
Stem Cells Transl Med. 2024; 13(4):387-398.
PMID: 38321361
PMC: 11016845.
DOI: 10.1093/stcltm/szae002.
Isoda M, Sanosaka T, Tomooka R, Mabuchi Y, Shinozaki M, Andoh-Noda T
Commun Biol. 2023; 6(1):611.
PMID: 37286713
PMC: 10247757.
DOI: 10.1038/s42003-023-04995-9.
Current status and prospects of regenerative medicine for spinal cord injury using human induced pluripotent stem cells: a review.
Inoue M, Yamaguchi R, He C, Ikeda A, Okano H, Kohyama J
Stem Cell Investig. 2023; 10:6.
PMID: 36970397
PMC: 10036917.
DOI: 10.21037/sci-2022-037.
Cell transplantation to repair the injured spinal cord.
Hall A, Fortino T, Spruance V, Niceforo A, Harrop J, Phelps P
Int Rev Neurobiol. 2022; 166:79-158.
PMID: 36424097
PMC: 10008620.
DOI: 10.1016/bs.irn.2022.09.008.
Morphological Characterization of Astrocytes in a Xenograft of Human iPSCDerived Neural Precursor Cells.
Voronkov D, Stavrovskaya A, Guschina A, Olshansky A, Lebedeva O, Eremeev A
Acta Naturae. 2022; 14(3):100-108.
PMID: 36348713
PMC: 9611864.
DOI: 10.32607/actanaturae.11710.
Xeno-free induced pluripotent stem cell-derived neural progenitor cells for in vivo applications.
Rust R, Weber R, Generali M, Kehl D, Bodenmann C, Uhr D
J Transl Med. 2022; 20(1):421.
PMID: 36114512
PMC: 9482172.
DOI: 10.1186/s12967-022-03610-5.
Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests.
Yamamoto T, Sato Y, Yasuda S, Shikamura M, Tamura T, Takenaka C
Stem Cells Transl Med. 2022; 11(5):527-538.
PMID: 35445254
PMC: 9154342.
DOI: 10.1093/stcltm/szac014.
Postsynaptic structure formation of human iPS cell-derived neurons takes longer than presynaptic formation during neural differentiation in vitro.
Togo K, Fukusumi H, Shofuda T, Ohnishi H, Yamazaki H, Hayashi M
Mol Brain. 2021; 14(1):149.
PMID: 34629097
PMC: 8504131.
DOI: 10.1186/s13041-021-00851-1.
First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol.
Sugai K, Sumida M, Shofuda T, Yamaguchi R, Tamura T, Kohzuki T
Regen Ther. 2021; 18:321-333.
PMID: 34522725
PMC: 8427225.
DOI: 10.1016/j.reth.2021.08.005.
Phosphorylation of GAP-43 T172 is a molecular marker of growing axons in a wide range of mammals including primates.
Okada M, Kawagoe Y, Sato Y, Nozumi M, Ishikawa Y, Tamada A
Mol Brain. 2021; 14(1):66.
PMID: 33832520
PMC: 8034164.
DOI: 10.1186/s13041-021-00755-0.
The Immunomodulatory Capacity of Induced Pluripotent Stem Cells in the Post-stroke Environment.
Spellicy S, Hess D
Front Cell Dev Biol. 2021; 9:647415.
PMID: 33796535
PMC: 8007866.
DOI: 10.3389/fcell.2021.647415.
The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models.
MacDougall G, Brown L, Kantor B, Chiba-Falek O
Mol Ther. 2021; 29(3):949-972.
PMID: 33429080
PMC: 7934639.
DOI: 10.1016/j.ymthe.2021.01.001.
iPSC for modeling neurodegenerative disorders.
Valadez-Barba V, Cota-Coronado A, Hernandez-Perez O, Lugo-Fabres P, Padilla-Camberos E, Diaz N
Regen Ther. 2021; 15:332-339.
PMID: 33426236
PMC: 7770414.
DOI: 10.1016/j.reth.2020.11.006.
A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
Kamata Y, Isoda M, Sanosaka T, Shibata R, Ito S, Okubo T
Stem Cells Transl Med. 2020; 10(3):398-413.
PMID: 33226180
PMC: 7900588.
DOI: 10.1002/sctm.20-0269.
Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington's Disease.
Yoon Y, Kim H, Hong C, Li E, Jeon I, Park H
Front Neurosci. 2020; 14:558204.
PMID: 33071737
PMC: 7530284.
DOI: 10.3389/fnins.2020.558204.
CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss.
Farooq R, Hussain K, Tariq M, Farooq A, Mustafa M
J Appl Genet. 2020; 61(1):51-65.
PMID: 31912450
DOI: 10.1007/s13353-019-00535-6.
In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
Tanimoto Y, Yamasaki T, Nagoshi N, Nishiyama Y, Nori S, Nishimura S
Stem Cells Transl Med. 2020; 9(4):465-477.
PMID: 31904914
PMC: 7103627.
DOI: 10.1002/sctm.19-0150.